Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
Kelly, Karen, Altorki, Nasser K, Eberhardt, Wilfried E E, O'Brien, Mary E R, Spigel, David R, Crinò, Lucio, Tsai, Chun-Ming, Kim, Joo-Hang, Cho, Eun Kyung, Hoffman, Philip C, Orlov, Sergey V, Serwatowski, Piotr, Wang, Jiuzhou, Foley, Margaret A, Horan, Julie D, Shepherd, Frances A
Published in Journal of clinical oncology (01.12.2015)
Published in Journal of clinical oncology (01.12.2015)
Get full text
Journal Article
Phase I, Pharmacokinetic and Biological Correlative Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor, and Cisplatin in Patients with Solid Tumors
RICART, Alejandro D, BERLIN, Jordan D, ROWINSKY, Eric K, ROTHENBERG, Mace L, PAPADOPOULOS, Kyriakos P, SYED, Samira, DROLET, Daniel W, QUARATINO-BAKER, Charlotte, HORAN, Julie, CHICK, Jon, VERMEULEN, Wendy, TOLCHER, Anthony W
Published in Clinical cancer research (01.12.2008)
Published in Clinical cancer research (01.12.2008)
Get full text
Journal Article
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study
Jakacki, Regina I., Foley, Margaret A., Horan, Julie, Wang, Jiuzhou, Kieran, Mark W., Bowers, Daniel C., Bouffet, Eric, Zacharoulis, Stergios, Gill, Stan C.
Published in Journal of neuro-oncology (01.08.2016)
Published in Journal of neuro-oncology (01.08.2016)
Get full text
Journal Article
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study
Cohen, Steven J., O’Neil, Bert H., Berlin, Jordan, Ames, Patricia, McKinley, Marti, Horan, Julie, Catalano, Patricia M., Davies, Angela, Weekes, Colin D., Leichman, Lawrence
Published in Cancer chemotherapy and pharmacology (01.04.2016)
Published in Cancer chemotherapy and pharmacology (01.04.2016)
Get full text
Journal Article
Common and rare EGFR mutations ( EGFR m) in the RADIANT trial: Final follow-up with 5 year data
Shepherd, Frances A., Eberhardt, Wilfried Ernst Erich, Altorki, Nasser K., O'Brien, Mary E.R., Wang, Joe, Wu, Jun, Gill, Stan, Iwata, Kenneth, Richardson, Frank C, Horan, Julie D., Foley, Margaret A., Kelly, Karen
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Final follow-up (f/u) results from RADIANT: A randomized double blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection in patients (pts) with stage IB–IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC)
O'Brien, Mary E.R., Kelly, Karen, Altorki, Nasser K., Eberhardt, Wilfried Ernst Erich, Spigel, David R., Crino, Lucio, Tsai, Chun-Ming, Kim, Joo-Hang, Cho, Eun Kyung, Hoffman, Philip C., Keshavjee, Shaf, Orlov, Sergey, Serwatowski, Piotr, Wang, Joe, Foley, Margaret A., Horan, Julie D., Shepherd, Frances A.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC): RADIANT trial
O'Brien, Mary E.R., Eberhardt, Wilfried Ernst Erich, Altorki, Nasser K., Spigel, David R., Crino, Lucio, Tsai, Chun-Ming, Cho, Eun Kyung, Kim, Joo-Hang, Szczesna, Aleksandra, Hoffman, Philip C., Burghuber, Otto, Keshavjee, Shaf, Orlov, Sergey, Serwatowski, Piotr, Wang, Jiuzhou, Foley, Margaret A., Horan, Julie D., Park, Jung Wook, Shepherd, Frances A., Kelly, Karen
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A randomized, double-blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC): RADIANT results
Kelly, Karen, Altorki, Nasser K., Eberhardt, Wilfried Ernst Erich, O'Brien, Mary E.R., Spigel, David R., Crino, Lucio, Tsai, Chun-Ming, Kim, Joo-Hang, Cho, Eun Kyung, Szczesna, Aleksandra, Burghuber, Otto, Hoffman, Philip C., Keshavjee, Shaf, Orlov, Sergey, Serwatowski, Piotr, Wang, Jiuzhou, Foley, Margaret A., Horan, Julie D., Park, Jung Wook, Shepherd, Frances A.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Adjuvant erlotinib (E) versus placebo (P) in non-small cell lung cancer (NSCLC) patients (pts) with tumors carrying EGFR- sensitizing mutations from the RADIANT trial
Shepherd, Frances A., Altorki, Nasser K., Eberhardt, Wilfried Ernst Erich, O'Brien, Mary E.R., Spigel, David R., Crino, Lucio, Tsai, Chun-Ming, Kim, Joo-Hang, Cho, Eun Kyung, Szczesna, Aleksandra, Burghuber, Otto, Hoffman, Philip C., Keshavjee, Shaf, Orlov, Sergey, Serwatowski, Piotr, Wang, Jiuzhou, Foley, Margaret A., Horan, Julie D., Richardson, Frank C, Kelly, Karen
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Enterprise information management system and methods
SUNKARA SATYA S, NIEHOFF GREGORY P, JUNG MARK A, SYED SAFDAR R, DATLA RAYAPA S, CAMPBELL-KAMINSKI ELIZABETH E, HERGENRATHER CAROL M, THOMPSON MICHAEL R, HORAN JULIE L, SMITH LISA D, JOHNSTON TERESA J, WARD JAMIE A, BURKHART TAL D, MATTHEWS MARY J
Year of Publication 23.12.2003
Get full text
Year of Publication 23.12.2003
Patent
Enterprise information management system and methods
Thompson, Michael R, Burkhart, Tal D, Smith, Lisa D, Niehoff, Gregory P, Ward, Jamie A, Horan, Julie L, Jung, Mark A, Datla, Rayapa S, Syed, Safdar R, Sunkara, Satya S, Hergenrather, Carol M, Matthews, Mary J, Johnston, Teresa J, Campbell-Kaminski, Elizabeth E
Year of Publication 23.12.2003
Get full text
Year of Publication 23.12.2003
Patent